Latest news with #ThyrocareTechnologies
Economic Times
25-05-2025
- Health
- Economic Times
Rs 5,000 crore tycoon says real success is when others are 'jealous' of your mother
Tired of too many ads? Remove Ads About Dr. A. Velumani Renowned entrepreneur and billionaire Dr. Arokiaswamy Velumani recently took to social media platform X to share a heartfelt message that resonated with many. On Sunday, the visionary founder of Thyrocare Technologies posted a thoughtful statement urging men to uplift and cherish the women in their lives. His words read: 'Instead of allowing the women in your life to feel envious of others, treat them in a way that makes others envious of them.'Through this short but profound message, Dr. Velumani emphasized that this wisdom isn't just limited to romantic relationships. He explained that both sons and daughters have a role in ensuring their mothers feel respected, loved, and proud. 'It's not just your spouse,' he elaborated. 'True success is when people look at your mother and wish they were in her place.'A vocal supporter of traditional family values , Velumani frequently advocates for nurturing strong familial bonds. He is equally vocal about the importance of instilling discipline in children rather than spoiling them. Back in April, he commented on the negative impact of overindulgence, stating that pampered children often grow up with inflated egos and unrealistic expectations. His tweet warned, 'Increased stress stems from rising arrogance and entitlement. Dear parents, stop over-pampering.'Reflecting on years of observing young adults, he highlighted two contrasting parenting approaches. Children encouraged to tackle challenges on their own tend to become confident, self-assured, and resilient. Meanwhile, those raised under constant supervision and frequent comparisons often become anxious, insecure, and emotionally fragile. He strongly believes that these outcomes are less about wealth and more about the parenting philosophy Born on April 12, 1959, Dr. A. Velumani is a distinguished Indian businessman who built his empire from humble beginnings. As the founder of Thyrocare Technologies Ltd., headquartered in Navi Mumbai, he transformed diagnostic healthcare in India. He later launched Nuclear Healthcare Limited, a radiology-focused firm, broadening his impact in the medical testing and imaging sector comes from the village of Appanaickenpatti Pudur, located near Coimbatore in what was once part of the Madras State. His father worked the land as a farmer, while his mother, a homemaker, took on the responsibility of raising buffaloes and selling their milk to support the family.
Time of India
25-05-2025
- Health
- Time of India
Rs 5,000 crore tycoon says real success is when others are 'jealous' of your mother
— velumania (@velumania) About Dr. A. Velumani Renowned entrepreneur and billionaire Dr. Arokiaswamy Velumani recently took to social media platform X to share a heartfelt message that resonated with many. On Sunday, the visionary founder of Thyrocare Technologies posted a thoughtful statement urging men to uplift and cherish the women in their lives. His words read: 'Instead of allowing the women in your life to feel envious of others, treat them in a way that makes others envious of them.'Through this short but profound message, Dr. Velumani emphasized that this wisdom isn't just limited to romantic relationships. He explained that both sons and daughters have a role in ensuring their mothers feel respected, loved, and proud. 'It's not just your spouse,' he elaborated. 'True success is when people look at your mother and wish they were in her place.'A vocal supporter of traditional family values , Velumani frequently advocates for nurturing strong familial bonds. He is equally vocal about the importance of instilling discipline in children rather than spoiling them. Back in April, he commented on the negative impact of overindulgence, stating that pampered children often grow up with inflated egos and unrealistic expectations. His tweet warned, 'Increased stress stems from rising arrogance and entitlement. Dear parents, stop over-pampering.'Reflecting on years of observing young adults, he highlighted two contrasting parenting approaches. Children encouraged to tackle challenges on their own tend to become confident, self-assured, and resilient. Meanwhile, those raised under constant supervision and frequent comparisons often become anxious, insecure, and emotionally fragile. He strongly believes that these outcomes are less about wealth and more about the parenting philosophy Born on April 12, 1959, Dr. A. Velumani is a distinguished Indian businessman who built his empire from humble beginnings. As the founder of Thyrocare Technologies Ltd., headquartered in Navi Mumbai, he transformed diagnostic healthcare in India. He later launched Nuclear Healthcare Limited, a radiology-focused firm, broadening his impact in the medical testing and imaging sector comes from the village of Appanaickenpatti Pudur, located near Coimbatore in what was once part of the Madras State. His father worked the land as a farmer, while his mother, a homemaker, took on the responsibility of raising buffaloes and selling their milk to support the family.
Time of India
02-05-2025
- Business
- Time of India
He made Rs 7,000 crore wealth with ZERO loan. Now, he is warning Indians about 'EMI and Stress' trap
Dr. A. Velumani recently shared a tweet on three kinds of people who make money. According to him one category earns enough, but cannot manage the funds wisely, while another makes enough money and manages it well, thus leading to no financial stress. He pointed out a third category where one earns enough and also manages to grow their wealth. In a follow-up post, he shared a chart and pointed out the financial behaviour from the 1960s to the 1990s. #Pahalgam Terrorist Attack India's Rafale-M deal may turn up the heat on Pakistan China's support for Pakistan may be all talk, no action India brings grounded choppers back in action amid LoC tensions The Thyrocare founder shared his observations, and a chart from Paisabazaar that offers a sharp reflection on the evolving financial behaviour across generations. The graph highlights a striking trend—people are using credit products at increasingly younger ages. While those born in the 1960s waited until 47 to access credit, millennials born in the 1990s began their credit journeys by age 26. If extrapolated to Gen Z and the 2020s, we may soon see individuals engaging with credit in their early twenties or even teens. — velumania (@velumania) Velumani's commentary captures the underlying concern: the normalisation of debt is being mistaken for progress. His pointed remark—'Many feel and claim, the more the EMI, the happier is life'—sheds light on a cultural shift where consumerism and status symbols often mask underlying financial stress. By tying this to his earlier framework of three financial personas, he implies that most people fall into the first category—earning enough, but failing to manage it wisely, leading to chronic stress. His warning is subtle yet urgent: if younger generations continue this trajectory without financial literacy and restraint, stress levels could surge by 2050, fueled by mounting EMIS and lifestyle inflation. The antidote, as Velumani suggests, lies in wise saving, intelligent investing, and mindful living—choices that lead not only to wealth, but true peace of mind. Dr A Velumani and loan Born in a modest village in Tamil Nadu, Dr. A. Velumani's rise to prominence is a testament to grit and frugality. After starting his career as a government research scientist, he went on to build Thyrocare Technologies—one of India's most successful diagnostic chains—without ever taking a loan. His strategy was simple but powerful: spend less, reinvest profits, and scale sustainably. In 2021, Velumani made headlines when he sold a majority stake in Thyrocare to PharmEasy for Rs 4,500 crore. At the time, he owned over 66% of the company—a stake built entirely through years of disciplined reinvestment, not through borrowed capital or flashy fundraising. What sets him apart in today's startup-fueled, loan-heavy economy is his aversion to debt. 'I never borrowed money, not even once,' Velumani said in an interview to Value Research. For him, growth was never about chasing rapid expansion with risky capital. Instead, he championed what he calls incremental growth through reinvestment, believing it to be the most stable and responsible way to build a lasting business.
Economic Times
27-04-2025
- Business
- Economic Times
Smallcap rally fizzles out! Only 38 double-digit weekly gainers as India-Pakistan tensions escalate
The smallcap rally, which saw over 100 stocks delivering double-digit returns in the previous week, lost momentum sharply in the week gone by as only 38 stocks managed to clock double-digit gains. Analysts attribute this to profit booking set in after the recent sharp run-up. ADVERTISEMENT Rajratan Global Wire topped the smallcap gainers list with a 32% weekly gain, followed by Thyrocare Technologies (27.5%), Best Agrolife (27.4%), Peninsula Land (26.8%), and Carraro India (26.2%). Nearly 30 smallcaps, including Manorama Industries, Tanfac Industries, Mufin Green Finance, Butterfly Gandhimathi, and Welspun Specialty Solutions, delivered healthy weekly gains in the 10–20% range. In the midcap space, AU Small Finance Bank was the top performer, gaining 15%, followed by Tata Elxsi (14.5%), Coforge (12.1%) and Mphasis (11.6%). Among Sensex constituents, Tech Mahindra led the pack with an 11.9% gain, followed by HCL Technologies (9.8%) and Mahindra & Mahindra (6.8%). The sharp cooling in the number of double-digit gainers highlights that smallcap sentiment has turned cautious after last week's euphoria, with investors becoming more selective ahead of the earnings-heavy weeks ahead. ADVERTISEMENT Looking ahead, analysts expect stock-specific action to dominate with earnings season picking up pace. Foreign investors are likely to be on a wait-and-watch approach in the near term to overview the geopolitical tension. "However, India has historically shown resilience during such periods given the buoyant nature of its domestic economy. For long-term investors, it is fair to take this as an opportunity to accumulate quality stocks/sectors during further dips for long-term gains," said Vinod Nair, Head of Research, Geojit Financial Services. ADVERTISEMENT On the technical front, analysts say caution remains the need of the hour."Nifty has slipped after a consolidation on the daily chart, indicating a rise in bearish sentiment. Additionally, the index has fallen below its 200-DMA, signaling a potential re-entry into a bearish trend. Support is placed at 23800/23515 levels," said Rupak De, Senior Technical Analyst at LKP Securities. ADVERTISEMENT With data inputs from Ritesh Presswala (Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of Economic Times.) (You can now subscribe to our ETMarkets WhatsApp channel)
&w=3840&q=100)
Business Standard
25-04-2025
- Business
- Business Standard
This smallcap stock zooms 32% in 1 week, nears 52-week high. Do you own?
Thyrocare Technologies share price today: Share price of Thyrocare Technologies moved higher by 11 per cent to ₹938.65 on the BSE in Friday's intra-day trade in an otherwise weak market. The stock price of the smallcap company has recovered 13 per cent from its intra-day low of ₹830.90. In comparison, the BSE Sensex was down 0.33 per cent at 79,545 and BSE Smallcap index slipped 2 per cent at 14,906 at 02:01 pm. In the past two days, it jumped 22 per cent after the company reported a good set of numbers for the quarter ended March 2025. In the past one week, the stock price of the healthcare services provider has zoomed 32 per cent, as compared to 0.21 per cent decline in the BSE Sensex. It had hit a 52-week high of ₹1,053.05 on January 1, 2025. Thyrocare Technologies Q4 financial performance In the January to March 2025 quarter (Q4FY25), Thyrocare's consolidated net profit including exceptional items increased 24 per cent year-on-year (YoY) at ₹21.3 crore as compared to ₹17.2 crore a year ago, implying a rise of 24 per cent. The company's revenue for the quarter under review stood at ₹187.2 crore as compared to ₹154.2 crore a year ago, up 21 per cent. Reported earnings before interest, tax, depreciation and amortisation (Ebitda) jumped 70 per cent YoY at ₹57.4 crore as compared to ₹33.8 crore a year ago. Reported Ebitda margins improved 900 bps at 31 per cent from 22 per cent in Q4FY24. Diagnostics services industry The Indian diagnostics industry has emerged as a preferred play within the expanding healthcare landscape, driven by attractive margins and significant growth potential. The domestic diagnostics industry is projected to grow at a compound annual growth rate (CAGR) of over 10 per cent over the next five years. This growth trajectory will be fueled by rising factors such as the increasing prevalence of chronic diseases, growth in the geriatric population, rising demand for preventive tests, and government initiatives. The government's healthcare expenditure as a percentage of GDP in India is lower compared to other countries. However, it is on an upward trajectory, with estimates pegging it to reach around 3.2 per cent of GDP by FY33. This increase in Government Healthcare Expenditure is anticipated to correlate with a rise in GDP per capita, indicating a positive outlook for government investment in healthcare, the company said in its FY24 annual report. About Thyrocare Thyrocare Technologies is India's first and foremost advanced fully automated laboratory chain with a strong presence spread across India. Thyrocare focuses on providing quality and affordable diagnostic services to laboratories and hospitals. Many laboratories and hospital brands all over India use the comprehensive test profile menu offered by Thyrocare. Thyrocare has an extensive network of laboratories across India. Thyrocare has a franchise base of 11,000+ and processes 460,000+ diagnostic and screening investigations each night.
